When these switches were applied to colon cancer cells, the cancer cells reverted to a normal-like state, a result confirmed through molecular and cellular experiments as well as animal studies.

Laboratory experiments, including molecular and cellular studies, along with animal trials, confirmed that cancer cells could indeed be reverted to a state that closely resembles normal colon cells.

Professor Kwang-Hyun Cho's research team from the Department of Bio and Brain Engineering has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into ...

The team used CRISPR/Cas engineering of a colon cancer cell line with and without GalNAc-T6 to understand which proteins the enzyme helped attach sugars to, and what effect this had on the cells.

A team of scientists at The University of Texas M. D. Anderson Cancer Center has said that a two-drug combination destroys precancerous colon polyps with no effect on normal tissue.

Research Highlights Published: 24 June 2015 Cancer Colon-cancer cells made normal Nature 522, 394 (2015) Cite this article ...

Once deleted PDZK1IP1 was deleted, colon cancer growth slowed down, suggesting that PDZK1IP1 and its super enhancer could be targets for anti-cancer therapies.

Colon cancer is relatively common in the U.S. The American Cancer Society (ACS) estimates that it's the third-most common cancer (excluding skin) and more than 106,000 people will be diagnosed ...

"Paired drugs kill precancerous colon polyps, spare normal tissue." ScienceDaily. ScienceDaily, 29 March 2010. <www.sciencedaily.com / releases / 2010 / 03 / 100328170245.htm>.